Research News
View articles by month and year
-
MRI Better at Assessing Results of Chemo Before Surgery
Research shows that breast MRI before surgery is better at assessing how well a cancer responds to neoadjuvant treatment compared to more traditional assessment measures such as a physical exam, mammogram, or ultrasound.
-
Breast MRI Useful Before Breast Cancer Surgery
Breast MRI can play an important role in guiding surgery and treatment for breast cancer, independent of breast density.
-
Aggressive Screening Plan Not Needed After Benign Biopsy Results
More aggressive breast cancer screening may not make sense after a benign abnormal area is biopsied; following standard breast cancer screening guidelines for women with average breast cancer risk is appropriate.
-
Screening Mammograms Offer Benefits for Women Age 40 to 49
A study looking at the value of screening mammograms for women age 40 to 49 found two important benefits.
-
Automated Ultrasound for Women with Dense Breasts Approved by FDA Panel
An FDA expert panel has recommended that an automated ultrasound device be approved for breast cancer screening in women with dense breasts.
-
False Positive Mammogram Results Linked to Higher Breast Cancer Risk
A large study found that women who had a false positive mammogram result were more likely to be diagnosed with breast cancer in the future.
-
Adding Ultrasound and MRI to Annual Mammograms Helps Find More Cancers in Women with Dense Breasts
Screening plans that add ultrasound and MRI to annual mammograms improves breast cancer detection in women with dense breasts.
-
Regular Screening Mammograms Save Lives, but Cause Overdiagnoses
A Norwegian study found that while regular screening mammograms save lives, they also cause overdiagnoses of breast cancer.
-
Research Strongly Supports Regular Mammograms Starting at Age 40
Results from a large study strongly support the value of regular mammogram screenings starting at age 40.
-
Many Women Not Getting Recommended Breast Cancer Screening
National screening rates for colon, breast, and cervical cancer are low.
